Seeking Alpha

Ryan Savitz » Articles » CVD |

More on CVD by Ryan Savitz
Articles by Ticker

Latest Comments on Ryan Savitz's Articles

  1. ArtfulDodger on Stryker Corp Looks Good for Health Care Rebound: Name one area of the economy that the government has delved into... more »
  2. Tim Hiteshew on Stryker Corp Looks Good for Health Care Rebound: I am long SYK as well, but we may not see earnings improve for... more »
  3. khaz on Stryker Corp Looks Good for Health Care Rebound: Health care reform is a big headwind near term, no question. But... more »
  4. Mad Hedge Fund Trader on Stryker Corp Looks Good for Health Care Rebound: These stocks are discounting a new future. I met with Dr.... more »
  5. Ryan Vanzo on Stryker Corp Looks Good for Health Care Rebound: I agree, and am long SYK. Good luck with your Nittany Lion Fund,... more »
  6. donzelion on Downturn Has Transformed Drug Company Business Model: "It seems that for the current time period, it is more cost... more »
  7. TATyszka on Downturn Has Transformed Drug Company Business Model: To add to the above comment -- this, from a report from Turner... more »
  8. upndown1313 on Downturn Has Transformed Drug Company Business Model: Write facts, but wrong interpretation. Big Pharma spending at CRO... more »
  9. stevenm1968 on Teva: What's Next for the 'Generic Giant'?: There is some noise on the internet about Teva buying Watson and I... more »
  10. felixd on Abbott, Teva: Tough Enough to Withstand Rocky Market: I think the author here has missed the bigger point about the FDA... more »
  11. mdpath on Abbott, Teva: Tough Enough to Withstand Rocky Market: Is there any specific news to account for ABT's sudden decline or... more »
  12. Ryan Savitz on Teva: What's Next for the 'Generic Giant'?: Well if you look at the history of Teva and how they have grown,... more »
  13. Chris B on Teva: What's Next for the 'Generic Giant'?: So we should buy this company on the basis of how well they've... more »
  14. bbowen7 on Teva: What's Next for the 'Generic Giant'?: Acquisitions are complex, and require financial resources, a... more »
  15. Michael Eisenberg on Teva: What's Next for the 'Generic Giant'?: This is an incredibly well run company. I know the CFO who just... more »